This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Neuromodulators
From Proteopedia
(Difference between revisions)
| Line 56: | Line 56: | ||
*[[Treatments:AChE Inhibitor References]]<br /> | *[[Treatments:AChE Inhibitor References]]<br /> | ||
| + | =Adrenaline (Epinephrine)/Noradrenaline (Norepinephrine)= | ||
| + | *<scene name='82/829381/Cv/6'>Adrenaline (Epinephrine)</scene>. | ||
| + | *<scene name='82/829381/Cv/7'>Noradrenaline (Norepinephrine)</scene>. | ||
| + | *[[Phenylethanolamine N-methyltransferase]] (Noradrenaline N-Methyltransferase) catalyzes the conversion of norepinephrine (noradrenaline) to epinephrine (adrenaline). This is the last step in the conversion of tyrosine to adrenaline<ref>PMID:11591352</ref>. | ||
| + | ==[[Adrenergic receptor|Adrenergic receptors in general]]== | ||
| + | The [[Adrenergic receptor|adrenergic receptors]] are metabolic G protein-coupled receptors. They are the targets of catecholamines. The binding of an agonist to them causes a sympathetic response.<br /> | ||
| + | * The α-2 adrenergic receptor (A2AR) inhibits insulin or glucagons release.<br /> | ||
| + | * The β-1 adrenergic receptor (B1AR) increases cardiac output and secretion of rennin and ghrelin.<ref>PMID:23435379</ref><br /> | ||
| + | * The β-2 adrenergic receptor (B2AR) triggers many relaxation reactions. | ||
| + | ===β1 adrenergic receptor=== | ||
| + | |||
| + | *3D structures in [[Adrenergic receptor]]. | ||
| + | *[[UMass Chem 423 Student Projects 2011-1#Beta-1 Adrenergic GPCR|Beta-1 Adrenergic receptor]] | ||
| + | *G<sub>s</sub>: [[adenylate cyclase]] activated, cAMP up. | ||
| + | |||
| + | *β1-adrenergic agonists: | ||
| + | **Dobutamine, see [[UMass Chem 423 Student Projects 2011-1#Beta-1 Adrenergic GPCR|Beta-1 Adrenergic receptor]], [[2y00]], [[2y01]], [[6h7l]]. | ||
| + | **Isoprenaline, see [[UMass Chem 423 Student Projects 2011-1#Beta-1 Adrenergic GPCR|Beta-1 Adrenergic receptor]], [[2y03]]. | ||
| + | **Noradrenaline | ||
| + | **Carmoterol, see [[2y02]]. | ||
| + | **Salbutamol (Albuterol in USA), [[2y04]]. | ||
| + | *Beta blockers: | ||
| + | **Metoprolol | ||
| + | **Atenolol | ||
| + | **Bisoprolol | ||
| + | **Propranolol | ||
| + | **Timolol | ||
| + | **Nebivolol | ||
| + | **Vortioxetine | ||
| + | |||
| + | ===β2 adrenergic receptor=== | ||
| + | |||
| + | * The human β2 adrenergic receptor bound to a G-protein ([[3sn6]]) is featured in a scene above, and additional structures are on the [[Adrenergic receptor|Adrenergic receptor page]]. | ||
| + | *[[Beta-2 Adrenergic Receptor|Article Beta-2 Adrenergic Receptor by Wayne Decatur, David Canner, Dotan Shaniv, Joel L. Sussman, Michal Harel]] | ||
| + | *[[Beta-2 adrenergic receptor|Article Beta-2 adrenergic receptor by Joel L. Sussman, Tala Curry, Michal Harel, Jaime Prilusky]] | ||
| + | *[[Group:SMART:A Physical Model of the beta-Adrenergic Receptor]] | ||
| + | *G<sub>s</sub>: adenylate cyclase activated, cAMP up. For G<sub>s</sub> see [[Beta2 adrenergic receptor-Gs protein complex updated]]. | ||
| + | β2-adrenergic agonists: | ||
| + | **Salbutamol (Albuterol in USA) | ||
| + | **Bitolterol mesylate | ||
| + | **Formoterol | ||
| + | **Isoprenaline | ||
| + | **Levalbuterol | ||
| + | **Metaproterenol | ||
| + | **Salmeterol | ||
| + | **Terbutaline | ||
| + | **Ritodrine | ||
| + | *Beta blockers: | ||
| + | **Butoxamine | ||
| + | **Timolol | ||
| + | **Propranolol | ||
| + | **ICI-118,551 | ||
| + | **Paroxetine | ||
| + | |||
| + | ==[[Beta-adrenergic receptor kinase]]== | ||
| + | |||
| + | ==Monoamine oxidases (MAO)== | ||
| + | Monoamine oxidases (MAO) (EC 1.4.3.4) are a family of enzymes that catalyze the oxidation of monoamines including adrenaline, noradrenaline, serotonin and dopamine. | ||
| + | ===[[Monoamine oxidase]]=== | ||
| + | ===[[Monoamine oxidase b]]=== | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 12:05, 2 January 2022
| |||||||||||
References
- ↑ Martin JL, Begun J, McLeish MJ, Caine JM, Grunewald GL. Getting the adrenaline going: crystal structure of the adrenaline-synthesizing enzyme PNMT. Structure. 2001 Oct;9(10):977-85. PMID:11591352
- ↑ Huang J, Chen S, Zhang JJ, Huang XY. Crystal structure of oligomeric beta1-adrenergic G protein-coupled receptors in ligand-free basal state. Nat Struct Mol Biol. 2013 Apr;20(4):419-25. doi: 10.1038/nsmb.2504. Epub 2013 Feb, 24. PMID:23435379 doi:10.1038/nsmb.2504
